Dishman Carbogen Amcis Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
February 10, 2023 at 05:42 am EST
Share
Dishman Carbogen Amcis Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 6,397.9 million compared to INR 5,620.8 million a year ago. Revenue was INR 6,462.9 million compared to INR 5,811.2 million a year ago. Net income was INR 469.6 million compared to INR 353.8 million a year ago. Basic earnings per share from continuing operations was INR 3 compared to INR 2.26 a year ago. Diluted earnings per share from continuing operations was INR 3 compared to INR 2.26 a year ago.
For the nine months, sales was INR 17,943.6 million compared to INR 15,717 million a year ago. Revenue was INR 18,153.8 million compared to INR 16,107.5 million a year ago. Net income was INR 409.2 million compared to INR 625.9 million a year ago. Basic earnings per share from continuing operations was INR 2.61 compared to INR 3.99 a year ago. Diluted earnings per share from continuing operations was INR 2.61 compared to INR 3.99 a year ago.
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, and disinfectants. The Companyâs segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. Its Marketable Molecules segment manufactures and supplies intermediates, chemicals, and various products for pharmaceutical, cosmetic and related industries. It has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd. and Dishman Carbogen Amcis (Singapore) Pte. Ltd.
DISHMAN CARBOGEN AMCIS LIMITED 
